MARY JEAN MENDIZABAL: Open Payments
NPI 1902989908 · DES PLAINES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,471 in 82 payments from 11 companies in 2025. Trend: 2023 $1,155 · 2024 $1,124 · 2025 $1,471
Food & beverage: $1,471
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 22 | $312 |
| AstraZeneca Pharmaceuticals LP | 16 | $310 |
| Corcept Therapeutics | 24 | $280 |
| Indivior Inc. | 7 | $185 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Orexo US, Inc. | 6 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Amgen Inc. | 1 | $19 |
Products named: BRIXADI, FARXIGA, Korlym, SUBLOCADE, ABILIFY MAINTENA, Zubsolv, JARDIANCE, SPRAVATO.
Industry payments across IL — which companies pay providers there.
